WaferGen to Present at Leerink Swann Life Science Tools and Diagnostics Roundtable
Contact:
WaferGen
Don Huffman, CFO
Don.Huffman@wafergen.com
510-651-4450
Media contact:
Joyce Strand
Joyce.Strand@wafergen.com
Investor contact:
Timothy Ryan
tryan@shorehamgroupllc.com
212-242-7777
Fremont, Calif., July 28, 2011 — WaferGen Biosystems, Inc. (OTCBB:WGBS), a leading developer of
state-of-the-art genomic analysis systems, today announced it will participate in the Leerink Swann Life Science Tools and Diagnostics Roundtable Conference in New York, at the Le Parker Meridien Hotel, on Wednesday, August 3, 2011.
The company’s remarks will be webcast live beginning at 11:30 a.m. Eastern time. The presentation may be accessed at www.wafergen.com and will be available for 90 days.
WaferGen Biosystems, Inc. develops, manufactures and sells state-of-the-art systems for genomic analysis
for the life science and pharmaceutical industries to advance next generation sequencing and ultimately personalized medicine. The company recently closed a $30.6 million financing of equity and debt with three leading institutional life science investors, Great Point Partners, LLC, Deerfield Management and Merlin Nexus, and certain members of the Board and management.
WaferGen offers the breakthrough SmartChip Real-Time PCR System, a next-generation Real-Time PCR system for discovery and validation of gene expression patterns (biomarkers) on a single platform. The high throughput capabilities of the SmartChip System enable researchers to extend their research across large panels of genes, and hundreds of samples, at a very reasonable cost.
The SmartChip System provides a range of high-throughput capabilities including microRNA and oncology gene expression profiling and Single Nucleotide Polymorphism (SNP) genotyping. WaferGen also offers Quick-Turnaround SmartChip Custom (User-Defined) Panels to enable validation studies of specific genes of interest through customization of high-throughput,real-time PCR SmartChip assay panels—all on a quick-turnaround basis.
In addition, the company offers an innovative fee-based service for gene-expression profiling using the SmartChip System. For additional information, please see http://www.wafergen.com.
# # #